19 June 2013
Keywords: a-viral, completes, ph, new, hiv, drug, norwegian
Article | 23 November 2000
Norwegian biotechnology firm A-Viral AS has completed a Phase Iclinical trial in the Philippines of its anti-HIV agent AV-1101. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.